MedPath

A clinical study on improvement of asthma control level in patients with refractory asthma by Ba Duan Jin Lung rehabilitation exercise

Not Applicable
Conditions
12/5000 Rheumatic immune disease associated with pulmonary interstitial disease
Registration Number
ITMCTR2000003825
Lead Sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria of western medicine for this disease;
2. Meet the diagnostic criteria of TCM syndrome differentiation and classification of this disease;
3. Patients willing to actively cooperate with relevant examinations during the study;
4. Patients were enrolled under the condition of informed consent and signed informed consent;
5. For patients with pulmonary imaging manifestations that are typical but not clearly diagnosed and suspected to be rheumatic immune diseases mentioned above, 11 immunizations, ANA, ENA, dsDNA, ACL, ANCA, complement, and esR should be examined. Patients with rheumatic immunology disease may be clinically diagnosed by an experienced rheumatologist before they are included in the study.

Exclusion Criteria

1. Patients with other pulmonary diseases, such as bronchitis, chronic obstructive pulmonary disease, bronchiectasis, pleurisy, pulmonary hypertension, pulmonary tuberculosis, lung tumor, etc.;
2. Patients with other organs such as cardiovascular, liver, kidney, hematopoietic system and other serious primary diseases and psychosis;
3. Patients who do not agree to participate in this study.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HRCT of the lung score;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath